Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity

Innovent · Phase 1 · Completed · Enrollment 36

NCT06536023

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
362-dose1-4mgn/rn/rn/rn/r
362-dose2-6mgn/rn/rn/rn/r
362-dose3-Placebon/rn/rn/rn/r

Not shown

  • 362-dose1-4mg: endpoint not reported
  • 362-dose2-6mg: endpoint not reported
  • 362-dose3-Placebo: endpoint not reported